Antiangiogenic nanotherapy for the control of obesity
Author:
Affiliation:
1. Faculty of Pharmaceutical Sciences, Hokkaido University, Kita 12, Nishi 6, Kita-ku, Sapporo, Hokkaido 060-0812, Japan
2. Faculty of Pharmaceutical Sciences, Hokkaido University, Kita 12, Nishi 6, Kita-ku, Sapporo, Hokkaido 060-0812, Japan.
Publisher
Future Medicine Ltd
Subject
Development,General Materials Science,Biomedical Engineering,Medicine (miscellaneous),Bioengineering
Link
https://www.futuremedicine.com/doi/pdf/10.2217/nnm.13.27
Reference20 articles.
1. Anti-obesity therapies
2. Review Paper: Current Strategies in the Development of Anti-obesity Drugs and Their Safety Concerns
3. A Review of the Microcirculation of Adipose Tissue: Anatomic, Metabolic, and Angiogenic Perspectives
4. Biological Action of Leptin as an Angiogenic Factor
5. Adipose tissue mass can be regulated through the vasculature
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advances in an active and passive targeting to tumor and adipose tissues;Expert Opinion on Drug Delivery;2014-11-07
2. Multifunctional envelope-type nano device for controlled intracellular trafficking and selective targeting in vivo;Journal of Controlled Release;2014-09
3. Comparative assessments of crucial factors for a functional ligand-targeted nanocarrier;Journal of Drug Targeting;2014-05-07
4. The role of philosophy of science in Responsible Research and Innovation (RRI): the case of nanomedicine;Life Sciences, Society and Policy;2014-04-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3